Shai Kalansky

Shai Kalansky

Education

University of California, San Diego (B.A., 2003)
Georgetown University Law Center (J.D., 2008)

Bar Admissions

New York
California

Shai Kalansky is an associate in the Corporate Department of Morrison & Foerster’s San Diego office and head of the Israel desk. His practice focuses on general corporate and transactional matters, including mergers and acquisitions. He assists public and private companies with a broad range of securities offerings, including registered direct offerings, PIPE transactions, underwritten deals and venture capital financings. Mr. Kalansky also provides guidance to public company clients on various disclosure and compliance related matters. He advises clients with respect to licensing matters and commercial contracts. Mr. Kalansky also counsels employers regarding employment agreements, personnel policies, and discrimination claims.

Mr. Kalansky is fluent in Hebrew and conversant in Spanish.

Fulgent Genetics Initial Public Offering
Represented Fulgent Genetics, Inc. (NASDAQ: FLGT), a comprehensive genetic testing company, as issuer’s counsel on its initial public offering.
Fulgent Genetics Preferred Financing
Represented Fulgent Genetics, Inc. (NASDAQ: FLGT), a comprehensive genetic testing company, in its preferred stock financing of over $27 million.
Cherokee Inc.’s Acquisition and Simultaneous Disposition of Hi-Tec
Represented Cherokee in its acquisition of Hi-Tec Sports International Holdings B.V. and its simultaneous disposition of various operating assets in the United States, Canada, Europe and Africa. Winner of the Transatlantic Legal Award in the M&A Team of the Year (Midmarket).
Natel Engineering Company’s $280 million acquisition of OnCore Manufacturing
Represented Natel in its acquisition of OnCore Manufacturing.
Sale of Biotix
Represented the sellers of Biotix Holdings Inc. in their sale of all outstanding equity of Biotix to Mettler-Toledo, LLC.
AMN Healthcare’s $160 million acquisition of B.E. Smith
Represented AMN in its acquisition of B.E. Smith.
AMN Healthcare’s $82 million acquisition of Onward Healthcare
Represented AMN in its acquisition of Onward Healthcare.
Sale of Mo Bio Laboratories
Represented the sellers of Mo Bio Laboratories in their sale of all outstanding equity of Mo Bio to Qiagen.
Netlist’s public offerings
Represented Netlist (NASDAQ: NLST), a producer of next generation persistent memory solutions, in its public offerings of common stock and warrants.
Venture Capital
Represented technology companies in venture financings with investments by venture capital firms and strategic investors.
Imprimis Pharmaceuticals, Inc. Acquisition of Compounding Pharmacy
Represented Imprimis in its acquisition of South Coast Specialty Compounding, Inc.
In re Fairfield Residential LLC, et al.
Currently represent the FFR Trust, the liquidating trust that was formed to liquidate the assets of Fairfield Residential LLC, a large multi-family and low income housing developer and property manager following its chapter 11 reorganization in its disposition of its assets.
Hitachi Metals, Ltd. Licensing
Represented Hitachi Metals, Ltd. in connection with patent license agreements and settlement agreements concluded in relation to an investigation at the U.S. International Trade Commission involving infringement of certain Hitachi Metals sintered rare earth magnet patents.

MoFo ScaleUp

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.